Jen Ge

Patent Agent

Jen Ge, Ph.D. focuses her practice on intellectual property in the biotechnology and pharmaceutical fields. Her practice includes drafting and prosecuting patent applications on, but is not limited to, antibody therapeutics, cancer immunotherapies, gene therapies, cell-based therapies, drug delivery, and diagnostic assays. She also conducts IP due diligence in mergers, acquisitions, IPOs, and other transactions, and performs patentability assessments and freedom-to-operate analyses. Jen also provides technical support for patent litigations in the biopharma space, and assists in infringement and validity opinions. Prior to joining Morgan Lewis, Jen was a patent agent at another major general practice law firm.